Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Alteogen Receives Ministry of Food and Drug Safety (MFDS) Approval for Tergase® 2024-07-08 21:00
DP Technology Announces Nomination of Development Candidate, a CNS Penetrable Lp-PLA2 Inhibitor for Alzheimer's Disease 2024-07-08 17:23
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME 2024-07-08 17:00
Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors 2024-07-08 16:28
BioCity announces its endothelin receptor A selective antagonist SC0062 met the primary endpoint in IgA nephropathy in 2-SUCCEED trial: a randomized, double-blind, placebo-controlled Phase 2 trial 2024-07-08 13:41
Hainan Free Trade Port deepens cooperation with Switzerland 2024-07-07 22:36
Hinova Pharmaceuticals receives FDA Fast Track Designation for HP518 for Treatment of AR+ Triple-Negative Breast Cancer (TNBC) 2024-07-05 21:00
IASO Bio and Innovent Enhance Strategic Collaboration in Cell Therapy 2024-07-05 16:30
Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis 2024-07-05 16:07
Zhejiang Doer Biologics Completes Enrollment of the Phase 1b/2a Trial Evaluating DR10624 in Obese Subjects with Modest Hypertriglyceridemia 2024-07-05 15:56
Bloomage Chairperson Zhao Yan Speaks on Sustainable Innovation at the 2024 Summer Davos Forum 2024-07-04 21:00
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus 2024-07-04 11:17
Datasea Announces Closing of $2.25 Million Registered Direct Offering 2024-07-04 04:30
Bloomage Ranks on World Brand Lab's China 500 Most Valuable Brands List 2024-07-02 21:00
Datasea Announces Pricing of $2.25 Million Registered Direct Offering 2024-07-02 20:30
Health In Tech, Adena Health, and OSU Health Plan Solutions Partner to Bring Affordable Level-Funded Health Plans to Ohio Employers 2024-07-02 20:30
Zepp Health Introduces Zepp OS 4: Redefining Wearable Intelligence by Integrating OpenAI's GPT-4o into its Amazfit Smartwatches 2024-07-02 16:00
PharmAbcine's Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration Advances to Both Single-dose of 4mg and Multiple-dose of 3mg 2024-07-02 11:02
Noul Co., Ltd. Releases 2023-2024 Sustainability Report 2024-07-02 10:52
Altos Biologics Files for Approval of Aflibercept Biosimilar 2024-07-02 08:00
1 36 37 38 39 40 812